论文信息 - Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations. - 字舞流文

Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations.

K. Soejima | K. Naoki | H. Terai | Keita Masuzawa | I. Kawada | J. Hamamoto | H. Yasuda | Keigo Kobayashi | S. Ikemura | S. Nukaga | Tetsuo Tani | Toshiyuki Hirano | Hanako Hasegawa | T. Manabe | Junko Hamamoto